IN8bio
IN8bio is a clinical-stage biopharmaceutical company focused on developing gamma-delta T cell therapies for cancer.
/10
Transparency ranking
Work at IN8bio?
Tell us what we're missing about working at IN8bio so we can make the job search more transparent for everyone.
Tell us what it's like to work at IN8bio!Description
IN8bio is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell therapies for solid and hematological tumors. Their DeltEx platform leverages allogeneic, autologous, iPSC, and genetically modified approaches to develop novel cell therapies designed to effectively identify and eradicate tumor cells. IN8bio is a leader in gamma-delta T cell therapies and was the first company to bring genetically modified gamma-delta T cells into the clinic. They have a robust pipeline of preclinical and clinical-stage programs, with lead product candidates currently in Phase 1 and Phase 2 trials.
IN8bio’s mission is to achieve CANCER ZERO - the elimination of all cancer cells in every patient battling the disease. Their core technology, DeltEx DRI, generates gamma-delta T cells resistant to chemotherapy, allowing for simultaneous administration of chemotherapy and immunotherapy, maximizing tumor killing and preventing resistance. IN8bio is headquartered in New York City, with primary scientific operations in Birmingham, Alabama.
Mission
IN8bio is a clinical-stage biopharmaceutical company dedicated to developing innovative gamma-delta T cell therapies for the treatment of both solid and hematological tumors. Their mission is to revolutionize cancer treatment by harnessing the unique properties of gamma-delta T cells, which naturally identify and eliminate diseased tissue. Through their DeltEx platform, they develop allogeneic, autologous, iPSC, and genetically modified cell therapies, aiming to effectively target and eradicate cancer cells, ultimately achieving their vision of "CANCER ZERO" - eliminating all cancer cells in every patient.
Culture
IN8bio fosters a collaborative and results-oriented culture driven by a shared passion for developing innovative cancer therapies. They emphasize teamwork, expertise, and a commitment to advancing therapeutic options for patients in need. The company is dedicated to leveraging its DeltEx platform and its team of experts in gamma-delta T cell biology and manufacturing to achieve its mission of CANCER ZERO - the elimination of all cancer cells in every patient.
Similar companies. But verified.
